West Virginia Senate Bill SB 317

West Virginia 2026 Regular Session

• Introduced: 1/15/26
• Refer: 1/15/26

Caption

Department of Agriculture rule relating to select plant-based derivatives and select plant-based derivative products of hemp and kratom

Summary

SB 317 is a rule-related bill concerning the West Virginia Department of Agriculture and its regulation of select plant-based derivatives and select plant-based derivative products derived from hemp and kratom. Based on the caption, the measure appears to address how these products are classified, regulated, or otherwise administered under department rules, rather than creating a broad new statutory program. The bill was referred to the Senate Judiciary Committee on January 15, 2026, indicating it was still in the committee process at the time of the provided information. Because the full bill text was not available in the provided materials, the precise legal changes cannot be identified from the text itself. However, the bill likely affects state agricultural and consumer-product regulation by clarifying the Department of Agriculture’s authority over hemp- and kratom-related derivatives and products. Any resulting impact would likely fall on producers, processors, distributors, retailers, and regulators dealing with these plant-based substances.

Impact

SB 317 appears to affect administrative rules under the Department of Agriculture rather than directly amending a large body of substantive law. Its practical impact would likely be on regulated businesses and enforcement agencies by defining or adjusting the treatment of certain hemp- and kratom-derived products under state agricultural rules. Depending on the final language, it could influence product compliance, labeling, sale, or oversight requirements for plant-based derivatives.

Sentiment

No committee transcript or recorded vote information was provided, so there is no direct evidence of support or opposition from debate. The bill’s referral to Judiciary suggests it was still under review and may have raised legal or regulatory questions requiring further examination. Overall sentiment cannot be determined with confidence from the available record, though the measure appears to be a technical regulatory bill rather than a highly publicized policy proposal.

Contention

The main likely points of contention are the scope of the Department of Agriculture’s authority, the treatment of hemp-derived products, and the regulation of kratom-related products, which can raise concerns about consumer safety, product legality, and industry compliance. Stakeholders that may differ include agricultural producers and retailers seeking clear rules, versus regulators or public-health advocates concerned about intoxicating or otherwise untested derivatives. Without transcripts, however, these concerns are inferred from the bill caption rather than documented debate.